Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

When the body becomes no more than the sum of its parts: the neural correlates of scrambled versus intact sexualized bodies.

Bernard P, Content J, Deltenre P, Colin C.

Neuroreport. 2018 Jan 3;29(1):48-53. doi: 10.1097/WNR.0000000000000926.

PMID:
29189635
2.

Biochemical and immunological characterization of a cpn60.1 knockout mutant of Mycobacterium bovis BCG.

Wang XM, Lu C, Soetaert K, S'Heeren C, Peirs P, Lanéelle MA, Lefèvre P, Bifani P, Content J, Daffé M, Huygen K, De Bruyn J, Wattiez R.

Microbiology. 2011 Apr;157(Pt 4):1205-19. doi: 10.1099/mic.0.045120-0. Epub 2010 Dec 2.

PMID:
21127129
3.

Effect of PstS sub-units or PknD deficiency on the survival of Mycobacterium tuberculosis.

Vanzembergh F, Peirs P, Lefevre P, Celio N, Mathys V, Content J, Kalai M.

Tuberculosis (Edinb). 2010 Nov;90(6):338-45. doi: 10.1016/j.tube.2010.09.004. Epub 2010 Oct 8.

PMID:
20933472
4.

Mechanisms of induction and action of interferons.

Content J.

Verh K Acad Geneeskd Belg. 2009;71(1-2):51-71. Review.

PMID:
19739398
5.

IS1096-mediated DNA rearrangements play a key role in genome evolution of Mycobacterium smegmatis.

Wang XM, Galamba A, Warner DF, Soetaert K, Merkel JS, Kalai M, Bifani P, Lefèvre P, Mizrahi V, Content J.

Tuberculosis (Edinb). 2008 Sep;88(5):399-409. doi: 10.1016/j.tube.2008.02.003. Epub 2008 Apr 24.

PMID:
18439874
6.

Optimization of polymerase chain reaction for detection of Clostridium botulinum type C and D in bovine samples.

Prévot V, Tweepenninckx F, Van Nerom E, Linden A, Content J, Kimpe A.

Zoonoses Public Health. 2007;54(8):320-7.

7.

Cloning, sequencing, and cell surface expression pattern of bovine immunoreceptor NKG2D and adaptor molecules DAP10 and DAP12.

Fikri Y, Nyabenda J, Content J, Huygen K.

Immunogenetics. 2007 Aug;59(8):653-9. Epub 2007 May 26.

PMID:
17530242
8.

A derivative of Mycobacterium smegmatis mc(2)155 that lacks the duplicated chromosomal region.

Warner DF, Etienne G, Wang XM, Matsoso LG, Dawes SS, Soetaert K, Stoker NG, Content J, Mizrahi V.

Tuberculosis (Edinb). 2006 Nov;86(6):438-44. Epub 2005 Dec 15.

PMID:
16359921
9.

Expression of a bioactive recombinant human interleukin-11 in chicken HD11 cell line.

Léon A, Wang XM, Champion-Arnaud P, Sobczyk A, Pain B, Content J, Jacques Y, Valarché I.

Cytokine. 2005 Jun 21;30(6):382-90.

PMID:
15869884
10.

Mycobacterium tuberculosis with disruption in genes encoding the phosphate binding proteins PstS1 and PstS2 is deficient in phosphate uptake and demonstrates reduced in vivo virulence.

Peirs P, Lefèvre P, Boarbi S, Wang XM, Denis O, Braibant M, Pethe K, Locht C, Huygen K, Content J.

Infect Immun. 2005 Mar;73(3):1898-902.

11.

Antimycobacterial activity of synthetic pamamycins.

Lefèvre P, Peirs P, Braibant M, Fauville-Dufaux M, Vanhoof R, Huygen K, Wang XM, Pogell B, Wang Y, Fischer P, Metz P, Content J.

J Antimicrob Chemother. 2004 Oct;54(4):824-7. Epub 2004 Aug 18.

PMID:
15317744
12.

Characterization of a potent human interleukin-11 agonist.

Harmegnies D, Wang XM, Vandenbussche P, Leon A, Vusio P, Grötzinger J, Jacques Y, Goormaghtigh E, Devreese B, Content J.

Biochem J. 2003 Oct 1;375(Pt 1):23-32.

13.

Effects of VOCs on herbaceous plants in an open-top chamber experiment.

Cape JN, Leith ID, Binnie J, Content J, Donkin M, Skewes M, Price DN, Brown AR, Sharpe AD.

Environ Pollut. 2003;124(2):341-53.

PMID:
12713933
15.

Engineering and use of (32)P-labeled human recombinant interleukin-11 for receptor binding studies.

Wang XM, Wilkin JM, Boisteau O, Harmegnies D, Blanc C, Vandenbussche P, Montero-Julian FA, Jacques Y, Content J.

Eur J Biochem. 2002 Jan;269(1):61-8.

16.

Disruption of adhC reveals a large duplication in the Mycobacterium smegmatis mc(2)155 genome.

Galamba A, Soetaert K, Wang XM, De Bruyn J, Jacobs P, Content J.

Microbiology. 2001 Dec;147(Pt 12):3281-94.

PMID:
11739760
17.

Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer.

Tanghe A, Content J, Van Vooren JP, Portaels F, Huygen K.

Infect Immun. 2001 Sep;69(9):5403-11.

18.

Molecular and biochemical characterisation of Mycobacterium smegmatis alcohol dehydrogenase C.

Galamba A, Soetaert K, Buyssens P, Monnaie D, Jacobs P, Content J.

FEMS Microbiol Lett. 2001 Mar 1;196(1):51-6.

19.
20.

Vaccinia expression of Mycobacterium tuberculosis-secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of M. tuberculosis Ag85.

Malin AS, Huygen K, Content J, Mackett M, Brandt L, Andersen P, Smith SM, Dockrell HM.

Microbes Infect. 2000 Nov;2(14):1677-85.

PMID:
11137041
21.

Mycobacterium intracellulare as a cause of a recurrent granulomatous tenosynovitis of the hand.

Lefèvre P, Gilot P, Godiscal H, Content J, Fauville-Dufaux M.

Diagn Microbiol Infect Dis. 2000 Oct;38(2):127-9.

PMID:
11035246
22.
23.

The ATP binding cassette (ABC) transport systems of Mycobacterium tuberculosis.

Braibant M, Gilot P, Content J.

FEMS Microbiol Rev. 2000 Oct;24(4):449-67. Review. Erratum in: FEMS Microbiol Rev 2002 Mar;26(1):109.

24.

What are the immunologically active components of bacille Calmette-Guérin in therapy of superficial bladder cancer?

Zlotta AR, Van Vooren JP, Denis O, Drowart A, Daffé M, Lefèvre P, Schandene L, De Cock M, De Bruyn J, Vandenbussche P, Jurion F, Palfliet K, Simon J, Schulman CC, Content J, Huygen K.

Int J Cancer. 2000 Sep 15;87(6):844-52.

25.
26.

Lack of protection in mice and necrotizing bronchointerstitial pneumonia with bronchiolitis in guinea pigs immunized with vaccines directed against the hsp60 molecule of Mycobacterium tuberculosis.

Turner OC, Roberts AD, Frank AA, Phalen SW, McMurray DM, Content J, Denis O, D'Souza S, Tanghe A, Huygen K, Orme IM.

Infect Immun. 2000 Jun;68(6):3674-9.

27.

Effect of ibuprofen and diethylcarbamazine on the hemodynamic and inflammatory response to endotoxin in the dog.

Pinsky MR, Roman A, Buurman W, Content J, Vincent JL.

Eur Surg Res. 2000;32(2):74-86.

PMID:
10810212
28.
29.

Listeria monocytogenes possesses adhesins for fibronectin.

Gilot P, André P, Content J.

Infect Immun. 1999 Dec;67(12):6698-701.

30.

Characterization of a Mycobacterium bovis BCG insertion sequence related to the IS21 family.

Lefèvre P, Braibant M, Content J, Gilot P.

FEMS Microbiol Lett. 1999 Sep 15;178(2):211-7. Erratum in: FEMS Microbiol Lett 2002 Jan 22;207(1):109.

31.

Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.

Smith SM, Malin AS, Pauline T, Lukey, Atkinson SE, Content J, Huygen K, Dockrell HM.

Infect Immun. 1999 Oct;67(10):5223-30.

32.

DNA vaccines against tuberculosis.

Ulmer JB, Montgomery DL, Tang A, Zhu L, Deck RR, DeWitt C, Denis O, Orme I, Content J, Huygen K.

Novartis Found Symp. 1998;217:239-46; discussion 246-53.

PMID:
9949812
33.

Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors.

Tanghe A, Lefèvre P, Denis O, D'Souza S, Braibant M, Lozes E, Singh M, Montgomery D, Content J, Huygen K.

J Immunol. 1999 Jan 15;162(2):1113-9.

34.

The interleukin-11/receptor complex: rational design of agonists/antagonists and immunoassays potentially useful in human therapy.

Jacques Y, Minvielle S, Müller-Newen G, Heinrich PC, Grötzinger J, Montero-Julian F, Brailly H, Wilkin JM, Content J.

Res Immunol. 1998 Sep-Oct;149(7-8):737-40. Review. No abstract available.

PMID:
9851534
35.

The proximal interferon-stimulated response elements are essential for interferon responsiveness: a promoter analysis of the antiviral MxA gene.

Ronni T, Matikainen S, Lehtonen A, Palvimo J, Dellis J, Van Eylen F, Goetschy JF, Horisberger M, Content J, Julkunen I.

J Interferon Cytokine Res. 1998 Sep;18(9):773-81.

PMID:
9781817
36.

Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.

Denis O, Tanghe A, Palfliet K, Jurion F, van den Berg TP, Vanonckelen A, Ooms J, Saman E, Ulmer JB, Content J, Huygen K.

Infect Immun. 1998 Apr;66(4):1527-33.

37.

Nomenclature of genes encoding aminoglycoside-modifying enzymes.

Vanhoof R, Hannecart-Pokorni E, Content J.

Antimicrob Agents Chemother. 1998 Feb;42(2):483. No abstract available.

38.
39.

Analysis of the mechanism of action of anti-human interleukin-6 and anti-human interleukin-6 receptor-neutralising monoclonal antibodies.

Kalai M, Montero-Julian FA, Brakenhoff JP, Fontaine V, De Wit L, Wollmer A, Brailly H, Content J, Grötzinger J.

Eur J Biochem. 1997 Nov 1;249(3):690-700.

40.

Heterologous expression of the Mycobacterium tuberculosis gene encoding antigen 85A in Corynebacterium glutamicum.

Salim K, Haedens V, Content J, Leblon G, Huygen K.

Appl Environ Microbiol. 1997 Nov;63(11):4392-400.

41.

Cloning of the antigen 85A from Mycobacterium gordonae and its use for the specific PCR identification of these mycobacteria.

Dumonceaux M, Fauville Dufaux M, Ooms J, De Wit L, Sonck P, Content J.

Mol Cell Probes. 1997 Aug;11(4):251-8.

PMID:
9281410
42.

Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex.

Lozes E, Huygen K, Content J, Denis O, Montgomery DL, Yawman AM, Vandenbussche P, Van Vooren JP, Drowart A, Ulmer JB, Liu MA.

Vaccine. 1997 Jun;15(8):830-3.

PMID:
9234526
43.

Expression and immunogenicity of Mycobacterium tuberculosis antigen 85 by DNA vaccination.

Ulmer JB, Liu MA, Montgomery DL, Yawman AM, Deck RR, DeWitt CM, Content J, Huygen K.

Vaccine. 1997 Jun;15(8):792-4.

PMID:
9234515
44.

Induction of humoral and cellular immune responses by vaccination with M. tuberculosis antigen 85 DNA.

Montgomery DL, Huygen K, Yawman AM, Deck RR, Dewitt CM, Content J, Liu MA, Ulmer JB.

Cell Mol Biol (Noisy-le-grand). 1997 May;43(3):285-92.

PMID:
9193782
45.

Three different putative phosphate transport receptors are encoded by the Mycobacterium tuberculosis genome and are present at the surface of Mycobacterium bovis BCG.

Lefèvre P, Braibant M, de Wit L, Kalai M, Röeper D, Grötzinger J, Delville JP, Peirs P, Ooms J, Huygen K, Content J.

J Bacteriol. 1997 May;179(9):2900-6.

46.

A serine/threonine protein kinase from Mycobacterium tuberculosis.

Peirs P, De Wit L, Braibant M, Huygen K, Content J.

Eur J Biochem. 1997 Mar 1;244(2):604-12.

47.

Analysis of the human interleukin-6/human interleukin-6 receptor binding interface at the amino acid level: proposed mechanism of interaction.

Kalai M, Montero-Julian FA, Grötzinger J, Fontaine V, Vandenbussche P, Deschuyteneer R, Wollmer A, Brailly H, Content J.

Blood. 1997 Feb 15;89(4):1319-33.

48.

Induction of immunity by DNA vaccination: application to influenza and tuberculosis.

Ulmer JB, Deck RR, DeWitt CM, Donnelly JJ, Friedman A, Montgomery DL, Yawman AM, Orme IM, Denis O, Content J, Huygen K, Liu MA.

Behring Inst Mitt. 1997 Feb;(98):79-86.

PMID:
9382773
49.

Characterization of the 6'-N-aminoglycoside acetyltransferase gene aac(6')-Im [corrected] associated with a sulI-type integron.

Hannecart-Pokorni E, Depuydt F, de wit L, van Bossuyt E, Content J, Vanhoof R.

Antimicrob Agents Chemother. 1997 Feb;41(2):314-8. Erratum in: Antimicrob Agents Chemother 1998 Feb;42(2):485.

50.

A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system.

Braibant M, Lefèvre P, de Wit L, Peirs P, Ooms J, Huygen K, Andersen AB, Content J.

Gene. 1996 Oct 17;176(1-2):171-6.

PMID:
8918249

Supplemental Content

Loading ...
Support Center